New Jersey · 2026-2027 Regular Session · Bill
A 1510: Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 1510 is a bill introduced in the New Jersey House on January 13, 2026. According to its official title, it concerns: Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*. Primary sponsor: Roy Freiman (Democratic), Sterley Stanley (Democratic). Most recent recorded action (June 4, 2026): Reported out of Assembly Comm. with Amendments, 2nd Reading.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Roy Freiman | Primary sponsor | Democratic | House | 16 |
| Sterley Stanley | Primary sponsor | Democratic | House | 18 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Reported out of Assembly Comm. with Amendments, 2nd Reading
- Introduced, Referred to Assembly Financial Institutions and Insurance Committee